Model
Edge
Seres Therapeutics
0001760671
Filing Type
4
Filing Date
4/7/2024
Updated
4/8/24, 2:45 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership